PLCB4 (phospholipase C beta 4)
| Gene | |
|
Entrez ID
Entrez Gene ID - the GENE ID in NCBI Gene database.
|
5332 |
|
Gene name
Gene Name - the full gene name approved by the HGNC.
|
Phospholipase C beta 4 |
|
Gene symbol
Gene Symbol - the official gene symbol approved by the HGNC.
|
PLCB4 |
|
Synonyms (NCBI Gene)
Gene synonyms aliases
|
ARCND2, ARCND2A, ARCND2B, PI-PLC |
|
Chromosome
Chromosome number
|
20 |
|
Chromosome location
Chromosomal Location - indicates the cytogenetic location of the gene or region on the chromosome.
|
20p12.3-p12.2 |
|
Summary
Summary of gene provided in NCBI Entrez Gene.
|
The protein encoded by this gene catalyzes the formation of inositol 1,4,5-trisphosphate and diacylglycerol from phosphatidylinositol 4,5-bisphosphate. This reaction uses calcium as a cofactor and plays an important role in the intracellular transduction |
|
SNPs
SNP information provided by dbSNP.
|
|||||||||||||||||||||||||
|
|||||||||||||||||||||||||
|
miRNA
miRNA information provided by mirtarbase database.
|
|||||||||||||||||||||||||
|
|||||||||||||||||||||||||
|
Gene ontology (GO)
Gene ontology information of associated ontologies with gene provided by GO database.
|
|||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||
|
Other IDs
Other ids provides unique ids of gene in databases such as OMIM, HGNC, ENSEMBLE.
|
|||||||
|
|||||||
| Protein | ||||||||||||||||||||||||||||||||||||
| UniProt ID | Q15147 | |||||||||||||||||||||||||||||||||||
| Protein name | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-4 (EC 3.1.4.11) (Phosphoinositide phospholipase C-beta-4) (Phospholipase C-beta-4) (PLC-beta-4) | |||||||||||||||||||||||||||||||||||
| Protein function | Activated phosphatidylinositol-specific phospholipase C enzymes catalyze the production of the second messenger molecules diacylglycerol (DAG) and inositol 1,4,5-trisphosphate (IP3) involved in G-protein coupled receptor signaling pathways. PLCB | |||||||||||||||||||||||||||||||||||
| Family and domains |
Pfam
|
|||||||||||||||||||||||||||||||||||
| Tissue specificity | TISSUE SPECIFICITY: Preferentially expressed in the retina. | |||||||||||||||||||||||||||||||||||
| Sequence | ||||||||||||||||||||||||||||||||||||
| Sequence length | 1175 | |||||||||||||||||||||||||||||||||||
| Interactions | View interactions | |||||||||||||||||||||||||||||||||||
|
Associated diseases
Disease associations categorized as Causal (pathogenic variants), Unknown (uncertain genetic evidence), or Text Mining (literature-based associations)
|
|||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||